Remodeling of mitochondrial dynamics by metabolic pathways couples to oncogenic growth in GNAS (Gα(s)) mutant pancreas cancer.

GNAS R201C mutation drives mitochondrial fusion in pancreatic cancer by regulating the BCAA pathway, supporting tumor growth despite KRAS mutations.

• Why it matters: Understanding how mitochondrial dynamics are controlled in cancer can reveal new therapeutic targets, especially since KRAS-mutant cancers typically maintain fissed mitochondria.
• What they did: The study analyzed pancreatic tumors with concurrent Kras G12D and GNAS R201C mutations using proteomics, microscopy, and metabolic experiments, identifying the BCAA pathway as a key regulator of mitochondrial shape.
• The result: Findings show that GNAS R201C promotes mitochondrial fusion via NADH-NAD+ metabolism, enabling oncogenic growth, and highlighting the interplay between signaling and metabolism in cancer cell mitochondrial regulation.